GT Biopharma, Inc. (GTBP)
Market Open
11 Sep, 14:44
NASDAQ (CM) NASDAQ (CM) Primary 
XMUN $
7. 43
+1.25
+20.3074%
$
6.61M Market Cap
- P/E Ratio
- Div Yield
106,901 Volume
-10.8 Eps
$ 6.18
Previous Close 
Want to track GTBP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
GT Biopharma, Inc. (GTBP) Statistics
Valuation metrics
Market Cap 6.61M
Enterprise value 2.64M
Trailing P/E (ttm) -0.06
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 2.62
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.13
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.16M
Average volume (90 days) 908.43K
Price summary
52-Week low 4.91
52-Week high 34.25
Beta -
50-Day moving average 0.31
200-Day moving average 0.4
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -0.01
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 8 Sep 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -3.82%
Return on equity -4.43%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.57
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.13
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 2.61%
Book value per share (mrq) 0.09
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
